NGNE – neurogene inc. (US:NASDAQ)
Stock Stats
News
Neurogene Inc. (NASDAQ: NGNE) was given a new $38.00 price target on by analysts at Robert W. Baird.
Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT™ Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome [Yahoo! Finance]
Neurogene Announces Peer-Reviewed Publication Demonstrating Gene Therapy Candidate NGN-401 with EXACT™ Technology Regulates Transgene Expression in Preclinical Models of Rett Syndrome
Neurogene Inc. (NASDAQ: NGNE) had its "outperform" rating re-affirmed by analysts at William Blair.
Neurogene Inc. (NASDAQ: NGNE) had its price target lowered by analysts at HC Wainwright from $55.00 to $50.00. They now have a "buy" rating on the stock.
Form EFFECT Neurogene Inc.
Form 424B3 Neurogene Inc.
Form EFFECT Neurogene Inc.
Form 4 Neurogene Inc. For: Mar 26 Filed by: Cvijic Christine Mikail
Form 4 Neurogene Inc. For: Mar 26 Filed by: Cobb Stuart
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.